Compare TGTX & SSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TGTX | SSL |
|---|---|---|
| Founded | 1993 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.4B |
| IPO Year | 2008 | 2002 |
| Metric | TGTX | SSL |
|---|---|---|
| Price | $64.36 | $12.15 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $69.43 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 11-09-2026 | 02-22-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1746.67 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $2,785,000.00 | N/A |
| Revenue This Year | $61.95 | $5.37 |
| Revenue Next Year | $35.55 | N/A |
| P/E Ratio | $120.60 | ★ $13.51 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.76 | $5.97 |
| 52 Week High | $68.03 | $18.19 |
| Indicator | TGTX | SSL |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 27.27 |
| Support Level | $52.12 | $12.04 |
| Resistance Level | $63.60 | $12.46 |
| Average True Range (ATR) | 3.52 | 0.47 |
| MACD | 0.14 | -0.41 |
| Stochastic Oscillator | 64.62 | 0.00 |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.